featured
ASCO-GI 2021: Addition of Investigational Bemarituzumab to Chemotherapy Shows Promise in Gastric Cancer
The benefits of the drug increased with greater FGFR2b expression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.